title: Attention-deficit/hyperactivity disorder: a neuropsychiatric disorder with childhood onset.
abstract: Attention-deficit/hyperactivity disorder (ADHD) is characterized by attentional problems such as hyperkinesia, restlessness and disturbances in timing. Environmental psychosocial factors interact with a genetic predisposition in causing measurable biological impairment. It is a common, persistent disorder of childhood that may change in manifestation with development from preschool through adult life. Untreated, it predisposes children to psychiatric and social pathology later in life. Unlike other psychiatric disorders of childhood, it can be successfully treated.
authors.affiliation: Child Neurology and Psychiatry, Department of Neuroscience, University of Cagliari, Italy. azuddas@vaxca1.unica.it
authors.forename: A
authors.initials: A
authors.lastname: Zuddas
authors.forename: B
authors.initials: B
authors.lastname: Ancilletta
authors.forename: P
authors.initials: P
authors.lastname: Muglia
authors.forename: C
authors.initials: C
authors.lastname: Cianchetti
mesh_terms: D000367:Age Factors; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D001921:Brain / Q000033:anatomy & histology / Q000378:metabolism*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D015928:Cognitive Behavioral Therapy / Q000379:methods; D003131:Combined Modality Therapy; D003469:Culture; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011379:Prognosis
chemical_list: D000929:Antidepressive Agents, Tricyclic; D000697:Central Nervous System Stimulants; D018377:Neurotransmitter Agents; D008774:Methylphenidate